FactR

FactR

ICO Ended
11,326 Views
Our mission is to bring decentralized, immutable Blockchain technologies to the logistics and freight industry, advancing and enhancing supply chain transparency, and enabling trusted global freight, fleet and logistics transactions management.
6.7
TOTAL SCORE
5.4
ICO PROFILE

(weight: 45%)

9
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
ICO Time: 01 June 2018 - 01 Oct 2018
Whitelist/KYC: Whitelist + KYC
Country: Hong Kong
Token info
Ticker: FTR
Platform: Stellar
Token Type: Stellar
Available for sale: 60,000,000 FTR
Financial
ICO Price: 1 FTR = 0.15 USD
Soft cap: 50,000.000 FTR
Hard cap: 60,000,000 FTR
Screenshots taken on 13 Aug 2018
Cory Skinner
CEO & Co-Founder
Participates in a number of projects
Huan Jin
CTO & Co-Founder
Participates in a number of projects
Andres Trivino
South America Partnerships Lead
Participates in a number of projects
Jenny Jin
Co-Founder, Logistics SME
No participating data
Steve Downer
Business Consultant, Blockchain
Participates in a number of projects
Guillermo Ginesta
Advisor
Participates in a number of projects
Michael Szucsik
Crypto Developer
Participates in a number of projects
Justinas Janulevicius
Advisor
Participates in a number of projects
Jason Cassidy
Advisor
Participates in a number of projects

Advisors (0)

HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Universal Reward Protocol
By accepting to share their shopping data with the network, a shopper earns reward tokens, while the data is used by retailers to build redemption offers that best suit each customer’s needs. Shoppers can redeem their tokens through these exclusive and personalized offers.
Upcoming
FinanceX
The FinanceX exchange platform enables users to trade using the local currency from a range of countries. This makes trading faster and easier as users can buy/sell cryptocurrencies directly instead of a slower and more difficult method using an intermediate, such as BTC or ETH. It also means that users can trade from many different countries with no added difficulty, setting us apart from other exchanges.
Upcoming
Invictus Margin Lending
The Invictus Margin Lending Fund offers investors the ability to take advantage of the volatile nature of the cryptocurrency market without risking direct exposure. The fund aims to maximize interest income on USD and USD equivalents with zero anticipated drawdown risk by taking dollar-based positions on margin lending platforms.
Upcoming
Beyond Seen Screen
Beyond Seen Screen has created a platform that enables interactivity with video content. With Beyond Seen Screen watching video content is no longer a passive action, a one-way street. The platform enables content producers and content distribution companies to link additional information to the video content. Viewers will no longer only passively receive adverts, trailers and other video content but will have ability to interactively engage with them by using their mobile device.
Active
Tempo
Tempo is a French licensed, Paris-based, European-wide anchor for Stellar blockchain payments. The company offers online, offline and digital backed remittances to nearly 100 destination countries with over 300 physical agent locations. Tempo is creating the easiest, fastest and most secure bridge between cash and crypto.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.